Lincocin

Lincomycin, the active ingredient in Lincocin, is a lincosamide presented as an oral dosage form for systemic use. It is employed to treat a range of bacterial infections, particularly those caused by anaerobic organisms, and is commonly prescribed for skin, soft‑tissue, bone and joint infections in adult patients.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches that meet EU regulatory standards and providing reliable logistics and regulatory support for cross‑border procurement.

Lincocin (lincomycin) is indicated for bacterial infections, especially those involving anaerobic organisms and related tissue sites.

- Skin and soft‑tissue infections: effective against susceptible Gram‑positive and anaerobic bacteria, helping resolve cellulitis and wound infections. - Bone and joint infections: used to treat osteomyelitis and septic arthritis caused by susceptible organisms. - Anaerobic intra‑abdominal infections: employed when anaerobic bacteria are implicated, aiding in infection control.

Adverse reactions may occur with lincomycin therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Rash: skin redness or itching. - Taste disturbance: altered taste perception.

Serious or Rare Side Effects: - Clostridioides difficile colitis: severe intestinal inflammation. - Anaphylaxis: life‑threatening allergic reaction. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Neutropenia: reduced neutrophil count increasing infection risk. - Thrombocytopenia: low platelet count leading to bleeding. - Pseudomembranous colitis: severe colonic inflammation.

When prescribing lincomycin, clinicians should consider several safety aspects.

- Renal impairment: adjust dose or monitor renal function. - Hepatic dysfunction: use with caution and monitor liver enzymes. - History of hypersensitivity: avoid if patient has known allergy to lincosamides. - Concomitant nephrotoxic drugs: increase risk of kidney injury, monitor closely. - Pregnancy and lactation: risk unknown; use only if benefit outweighs potential harm. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Lincomycin may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Erythromycin: competitive inhibition may increase lincomycin plasma levels. - Neuromuscular blocking agents: potentiation can cause respiratory muscle weakness. - Warfarin: may enhance anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Rifampin: enzyme induction may reduce lincomycin concentrations. - Aminoglycosides: combined use may increase nephrotoxicity. - Oral contraceptives: may reduce effectiveness, consider alternative contraception.